Do Kim analyst

Currently out of the existing stock ratings of Do Kim, 240 are a BUY (82.47%), 51 are a HOLD (17.53%).

Do Kim

Work Performance Price Targets & Ratings Chart

Analyst Do Kim, carries an average stock price target met ratio of 56.84% that have a potential upside of 37.19% achieved within 337 days. Previously, Do Kim worked at PIPER SANDLER, BMO, NOMURA.

Do Kim’s has documented 581 price targets and ratings displayed on 29 stocks. The coverage was on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on CDXS, Codexis at 15-Aug-2024.

Wall Street Analyst Do Kim

Analyst best performing recommendations are on AKCA (AKCEA THERAPEUTICS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 11/7/2016. The price target of $48 was fulfilled within 8 days with a profit of $15.88 (49.44%) receiving and performance score of 61.8.

Average potential price target upside

ABCL Abcellera Biologics AFMD Affimed NV AKCA Akcea Therapeutics ALNY Alnylam Pharmaceuticals AMGN Amgen BTAI BioXcel Therapeutics CNST Constellation Pharmaceuticals FATE Fate Therapeutics GILD Gilead Sciences HALO Halozyme Therapeutics IONS Ionis Pharmaceuticals MORF Morphic OBSV ObsEva SA RAPT RAPT Therapeutics REPL Replimune Group RIGL Rigel Pharmaceuticals RTRX Travere Therapeutics SDGR Schrodinger SRRK Scholar Rock Holding Corp TCRR Tcr2 Therapeutics TVTX Travere Therapeutics VBIV VBI Vaccines VRTX Vertex Pharmaceuticals NUVB Nuvation Bio EXEL Exelixis CDXS Codexis TAL TAL Education Group CNS Cohen & Steers CMPI Checkmate Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Sep-2026

$13

$-0.74 (-5.39%)

$24

9 days ago
(24-Sep-2026)

1/3 (33.33%)

$0.35 (2.77%)

4

Buy Since 05-Jan-2021

$9

$-4.74 (-34.50%)

$7

1 months 27 days ago
(06-Aug-2026)

4/8 (50%)

$2.47 (37.83%)

377

Buy Since 05-May-2026

$12

$-1.74 (-12.66%)

$7

1 months 27 days ago
(06-Aug-2026)

2/2 (100%)

$5.47 (83.77%)

33

Hold Since 05-Nov-2024

$11

$-2.74 (-19.94%)

2 months 26 days ago
(07-Jul-2026)

2/4 (50%)

$3.31 (43.04%)

561

Buy Since 10-Apr-2026

$11

$-2.74 (-19.94%)

$11

4 months 29 days ago
(04-May-2026)

2/2 (100%)

$6.41 (139.65%)

114

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?